Molecular Docking Of Withaferin A From Withania Somnifera With The Proteins Associated With Cancer Therapy

Authors

  • G. DEVIBALA , SIVAKUMAR. , KALIAPPAN ILANGO

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.163

Abstract

Withaferin-A, a member of the withanolides class, is an essential phytoconstituent of Withania somnifera (Ashwagandha). These are naturally occurring C28-steroidal lactone triterpenoids groupings. For several decades, Withaferin-A was in use for several decade to treat various disorders. Design and development of an effective compound to combat cancer is clearly critical in the current circumstances. Therefore, it is of interest to document the molecular docking analysis data of the different cancer therapy with Withaferin-A from Withania somnifera in the context of cancer for further consideration. Here, we report the optimal interaction features of Withaferin A, different cancer receptors having low binding energies -9.93, -8.34, -9.93, -8.03, -9.69, -6.10 kcal/mol respectively) in this report. In order to gain additional insights, the interaction pattern of compounds with anti- cancer activities was studied.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

Molecular Docking Of Withaferin A From Withania Somnifera With The Proteins Associated With Cancer Therapy. (2022). Journal of Pharmaceutical Negative Results, 1400-1408. https://doi.org/10.47750/pnr.2022.13.S10.163